Equatorial Guinea vs Vanuatu: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Equatorial Guinea
2.0%
in 2024
Vanuatu
1.8%
in 2024
Equatorial Guinea rank
12th
Vanuatu rank
14th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Equatorial Guinea
- Vanuatu
How they compare
Equatorial Guinea currently reports 2.0% against 1.8% in Vanuatu, a difference of 0.2%.
That makes Equatorial Guinea's figure about 1.1 times Vanuatu's.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Equatorial Guinea ranks 12th and Vanuatu ranks 14th of 215 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.3% | 1.6% | 0.7% | Equatorial Guinea |
| 2020s | 2.1% | 1.7% | 0.4% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Equatorial Guinea or Vanuatu?
- Equatorial Guinea, at 2.0% against 1.8% in Vanuatu as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Equatorial Guinea and Vanuatu?
- 0.2%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Vanuatu?
- 10 years are reported by both, from 2015 to 2024.
- How do Equatorial Guinea and Vanuatu rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Equatorial Guinea ranks 12th and Vanuatu ranks 14th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.